阿糖胞苷（NSC - 63878）和柔红霉素（NSC - 83142）治疗急性非淋巴细胞白血病。 - Suppr

Suppr

超能文献

Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.

作者信息

Yates J W, Wallace H J, Ellison R R, Holland J F

出版信息

Cancer Chemother Rep. 1973 Nov-Dec;57(4):485-8.

PMID:4586956

Abstract

摘要

相似文献

Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.阿糖胞苷（NSC - 63878）和柔红霉素（NSC - 83142）治疗急性非淋巴细胞白血病。

Cancer Chemother Rep. 1973 Nov-Dec;57(4):485-8.

Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.柔红霉素（NSC - 82151）、长春新碱（NSC - 67574）、阿糖胞苷（NSC - 63878）和泼尼松（NSC - 10023）联合治疗晚期成人急性白血病。

Cancer Chemother Rep. 1975 Jul-Aug;59(4):757-60.

Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.采用柔红霉素和阿糖胞苷治疗成人急性非淋巴细胞白血病

Cancer Treat Rep. 1977 Nov;61(8):1441-5.

Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.阿糖胞苷（NSC - 63878）和柔红霉素（NSC - 82151）在急性髓性白血病中的序贯治疗。

Cancer Treat Rep. 1976 May;60(5):629-31.

Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.柔红霉素（NSC - 82151）单独使用与柔红霉素、阿糖胞苷（NSC - 63878）、6 - 硫鸟嘌呤（NSC - 752）和乙胺嘧啶（NSC - 3061）联合使用治疗急性非淋巴细胞白血病的随机临床比较。

Cancer Treat Rep. 1976 Jan;60(1):41-53.

Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.阿霉素-阿糖胞苷疗法治疗成人急性髓细胞白血病。

Cancer Treat Rep. 1977 Jan-Feb;61(1):89-92.

Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.

Scand J Haematol. 1979 Aug;23(2):119-23.

Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.

Recent Results Cancer Res. 1973;43:165-8.

[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].

Bull Cancer. 1974 Jul-Sep;61(3):411-8.

Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).用阿糖胞苷（NSC - 63878）和环磷酰胺（NSC - 26271）联合治疗急性白血病。

Cancer Chemother Rep. 1970 Aug;54(4):255-62.

引用本文的文献

Comparative efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia treatment: a meta-analysis of clinical trials and Real-World outcomes.维奈托克与去甲基化药物在急性髓系白血病治疗中的疗效比较：一项临床试验与真实世界结果的荟萃分析

Ann Hematol. 2025 Aug 30. doi: 10.1007/s00277-025-06543-3.

Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.新诊断急性髓系白血病（AML）的适合与不适合患者治疗选择的最新进展

Curr Treat Options Oncol. 2025 Aug 23. doi: 10.1007/s11864-025-01351-3.

Early replacement of re-induction therapy following failed intensive induction treatment enhances the therapeutic efficacy of newly diagnosed AML.强化诱导治疗失败后早期更换再诱导治疗可提高新诊断急性髓系白血病的治疗效果。

Sci Rep. 2025 Jun 6;15(1):20022. doi: 10.1038/s41598-025-04139-5.

Drug development for leukemia: comprehensive analysis of clinical trials from first report to drug approval.白血病的药物研发：从首次报告到药物获批的临床试验综合分析

Blood Adv. 2025 Aug 12;9(15):3810-3813. doi: 10.1182/bloodadvances.2024014340.

From Chemotherapy to Targeted Therapy: Unraveling Resistance in Acute Myeloid Leukemia Through Genetic and Non-Genetic Insights.从化疗到靶向治疗：通过遗传学和非遗传学见解解析急性髓系白血病的耐药性

Int J Mol Sci. 2025 Apr 24;26(9):4005. doi: 10.3390/ijms26094005.

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management.急性髓系白血病：2025年诊断、风险分层及管理的最新进展

Am J Hematol. 2025 May;100(5):860-891. doi: 10.1002/ajh.27625. Epub 2025 Feb 12.

Regional disparities in the use of intensive chemotherapy for AML in the Netherlands: does it influence survival?荷兰急性髓系白血病强化化疗使用情况的地区差异：这会影响生存率吗？

BMJ Oncol. 2024 Jul 5;3(1):e000264. doi: 10.1136/bmjonc-2023-000264. eCollection 2024.

Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.急性髓系白血病强化治疗的结果：对来自HARMONY联盟二十年数据的分析

Haematologica. 2025 May 1;110(5):1126-1140. doi: 10.3324/haematol.2024.285805. Epub 2024 Nov 7.

Treatment of Acute Myeloid Leukemia in the Community Setting.社区环境下急性髓系白血病的治疗。

Oncologist. 2024 Sep 6;29(9):801-805. doi: 10.1093/oncolo/oyae051.

Effective Prevention and Treatment of Acute Leukemias in Mice by Activation of Thermogenic Adipose Tissues.通过激活生热脂肪组织有效预防和治疗小鼠急性白血病。

Adv Sci (Weinh). 2024 Oct;11(38):e2402332. doi: 10.1002/advs.202402332. Epub 2024 Jul 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验